Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- OTC NEWS IN BRIEF
June 25, 2001
- WORLD NEWS IN BRIEF
June 25, 2001
- Profitability Higher for Medical Equipment Importers Than Manufacturers: Survey
June 25, 2001
- Fukuda Denshi to Boost Sales to \100 Billion in 2010
June 25, 2001
- JMA President Criticizes Ceiling System for Medical Costs
June 25, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
June 25, 2001
- Drug Dispensing Costs Outgrow Bungyo: JMA
June 25, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
June 25, 2001
- REGULATORY NEWS IN BRIEF -2-
June 25, 2001
- Information on Physicians Most Wanted by Citizens: Survey
June 25, 2001
- REGULATORY NEWS IN BRIEF -1-
June 25, 2001
- Korosho Survey Shows Hypertension, Hyperlipidemia Increasing in Men Aged 30 to 50
June 25, 2001
- CEFP Calls For Review of Public Health Insurance Coverage
June 25, 2001
- More Disclosure Needed for Patient-oriented Medical Services: HPB Director General
June 25, 2001
- FPMAJ Proposes Authorized Price Reimbursement Method
June 25, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
June 25, 2001
- Ordinary Profit Ratio Averages 18.2% for 27 Listed Firms
June 25, 2001
- BUSINESS NEWS IN BRIEF -2-
June 25, 2001
- BUSINESS NEWS IN BRIEF -1-
June 25, 2001
- Globalization of Japanese Firms Discussed: UBS Warburg Conference
June 25, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…